Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: A randomized trial

JAMA

Volumn 293, Issue 8, 2005, Pages 949-955

  Hooton, Thomas M ^a,e   Scholes, Delia ^b,c   Gupta, Kalpana ^a,d   Stapleton, Ann E ^a   Roberts, Pacita L ^a   Stamm, Walter E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFECTION; SINGLE BLIND PROCEDURE; URINE CULTURE; VAGINA FLORA; ADULT; COMPARATIVE STUDY; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; VAGINA;

ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CYSTITIS; ESCHERICHIA COLI; FEMALE; HUMANS; SINGLE-BLIND METHOD; VAGINA;

EID: 13944278837     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.8.949     Document Type: Article

References (29)

1. Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med. 2002;162:41-47.
2. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 2003; 138:525-533.
3. Scheid WM. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis. 2003;9:1-9.
4. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29:745-758.
5. Counts GW, Stamm WE, McKevitt M, et al. Treatment of cystitis in women with a single dose of trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982; 4:484-490.
6. Pabich WL, Fihn SD, Stamm WE, et al. Prevalence and determinants of vaginal flora alterations in postmenopausal women. J Infect Dis. 2003;188:1054-1058.
7. Samadpour M, Grimm LM, Desai B, Alfi D, Ongerth JE, Tarr PI. Molecular epidemiology of Escherichia coli O157:H7 strains by bacteriophage lambda restriction fragment length polymorphism analysis: application to a multistate foodborne outbreak and a day-care center cluster. J Clin Microbiol. 1993;31:3179-3183.
8. Feinberg AP, Vogelstein E. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983;132:6-13.
9. Hooton TM, Stamm WE. The vaginal flora and UTIs. In: Mobley HLT, Warren JW, eds. UTIs: Molecular Pathogenesis and Clinical Management. Washington, DC: ASM Press; 1996:67.
10. Bailey RR. Continuing problems with the use of Augmentin for urinary tract infections. W Z Med J. 1995;108:465.
11. Mulvey MA, Lopez-Boado S, Wilson CL, et al. Induction and evasion of host defenses by type 1 piliated uropathogenic Escherichia coli [erratum in: Science. 1999;283:795]. Science. 1998;282:1494-1497.
12. Mulvey MA, Lopez-Boado S, Wilson CL, et al. Induction and evasion of host defenses by type 1 piliated uropathogenic Escherichia coli [erratum in: Science. 1999;283:795]. Science. 1998;282:1494-1497.
13. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A. 2000;97:8829-8835.
14. Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am. 2003;17:303-332.
15. Brumfitt W, Hamilton-Miller JM. Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections. Antimicrob Agents Chemother. 1984; 25:276-278.
16. Johnson CE, Maslow JN, Fattlar DC, et al. The role of bacterial adhesins in the outcome of childhood urinary tract infections. AJDC. 1993;147:1090-1093.
17. Gurwith MJ, Stein GE, Gurwith D. Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections. Antimicrob Agents Chemother. 1983;24:716-719.
18. Crokaert F, Van Der Linden MP, Yourassowsky E. Activities of amoxicillin and clavulanic acid combinations against urinary tract infections. Antimicrob Agents Chemother. 1982;22:346-349.
19. Williams KJ, Hebblethwaite EM, Brown GW, Cox DM, Plested SJ. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin. Drugs Exp Clin Res. 1987;13:95-99.
20. Cooper J, Raeburn A, Brumfitt W, Hamilton-Miller JM. Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice. Infection. 1990;18:65-69.
21. Schutz W. Treatment of uncomplicated urinary tract infections: effectiveness and tolerance of sultamicillin compared with amoxicillin/ clavulanic acid. Fortschr Med. 1990;108:365-368.
22. Casas Rodriguez J, Pallares Robles J, Guarga Rojas A, et al. Amoxicillin/clavulanic acid and trimethoprim in the treatment of urinary infection in primary care. Aten Primaria. 1990;7:127-130.
23. Bailey RR, Bishop V, Peddie B, Chambers PFM, Davies PR, Crofts HG. Comparison of augmentin with co-trimoxazole for treatment of uncomplicated urinary tract infections. N Z Med J. 1983;96:970-972.
24. Gallacher G, Erwin L, Scott PJ, Sleigh JD. Augmentin (amoxycillin- clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly. J Infect. 1986;12:229-233.
25. Masterton RG, Bochsler JA. High-dosage co-amoxiclav in a single dose versus 7 days of cotrimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother. 1995;35:129-137.
26. Raz R, Rottensterich E, Boger S, Potasman I. Comparison of single-dose administration and three-day course of amoxicillin with those of clavulanic acid for treatment of uncomplicated urinary tract infection in women. Antimicrob Agents Chemother. 1991;35:1688-1690.
27. Leflon-Guibout V, Ternat G, Heym B, Nicolas-Chanoine M-H. Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection. J Antimicrob Chemother. 2002;49:367-371.
28. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother. 2003;51:69-76.
29. Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis. 2004;39:75-80.